Identifying residual hotspots and mapping lower respiratory infection morbidity and mortality in African children from 2000 to 2017
-
Published:2019-09-30
Issue:12
Volume:4
Page:2310-2318
-
ISSN:2058-5276
-
Container-title:Nature Microbiology
-
language:en
-
Short-container-title:Nat Microbiol
Author:
Reiner Robert C.ORCID, Welgan Catherine A., Casey Daniel C., Troeger Christopher E., Baumann Mathew M., Nguyen QuynhAnh P., Swartz Scott J., Blacker Brigette F., Deshpande Aniruddha, Mosser Jonathan F., Osgood-Zimmerman Aaron E., Earl Lucas, Marczak Laurie B., Munro Sandra B., Miller-Petrie Molly K., Rodgers Kemp Grant, Frostad Joseph, Wiens Kirsten E., Lindstedt Paulina A., Pigott David M., Dwyer-Lindgren Laura, Ross Jennifer M., Burstein RoyORCID, Graetz Nicholas, Rao Puja C., Khalil Ibrahim A., Davis Weaver NicoleORCID, Ray Sarah E., Davis Ian, Farag Tamer, Brady Oliver J., Kraemer Moritz U. G.ORCID, Smith David L.ORCID, Bhatt Samir, Weiss Daniel J.ORCID, Gething Peter W., Kassebaum Nicholas J., Mokdad Ali H., Murray Christopher J. L., Hay Simon I.ORCID
Abstract
Abstract
Lower respiratory infections (LRIs) are the leading cause of death in children under the age of 5, despite the existence of vaccines against many of their aetiologies. Furthermore, more than half of these deaths occur in Africa. Geospatial models can provide highly detailed estimates of trends subnationally, at the level where implementation of health policies has the greatest impact. We used Bayesian geostatistical modelling to estimate LRI incidence, prevalence and mortality in children under 5 subnationally in Africa for 2000–2017, using surveys covering 1.46 million children and 9,215,000 cases of LRI. Our model reveals large within-country variation in both health burden and its change over time. While reductions in childhood morbidity and mortality due to LRI were estimated for almost every country, we expose a cluster of residual high risk across seven countries, which averages 5.5 LRI deaths per 1,000 children per year. The preventable nature of the vast majority of LRI deaths mandates focused health system efforts in specific locations with the highest burden.
Funder
Bill and Melinda Gates Foundation
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Microbiology (medical),Genetics,Applied Microbiology and Biotechnology,Immunology,Microbiology
Reference36 articles.
1. Roth, G. A. et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 392, 1736–1788 (2018). 2. Troeger, C. et al. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Infect. Dis. 18, 1191–1210 (2018). 3. Bhutta, Z. A. et al. Interventions to address deaths from childhood pneumonia and diarrhoea equitably: what works and at what cost? Lancet 381, 1417–1429 (2013). 4. Swingler, G., Fransman, D. & Hussey, G. Conjugate vaccines for preventing Haemophilus influenzae type B infections. Cochrane Database Syst. Rev. 4, CD001729 (2003). 5. Lucero, M. G. et al. Pneumococcal conjugate vaccines for preventing vaccine‐type invasive pneumococcal disease and X‐ray defined pneumonia in children less than two years of age. Cochrane Database Syst. Rev. 4, CD004977 (2009).
Cited by
37 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|